![Patrick Crutcher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Crutcher
Direktor/Vorstandsmitglied bei
JASPER THERAPEUTICS, INC.
Vermögen: 9 Mio $ am 30.09.2026
Profil
Patrick J.
Crutcher was the founder of Mach5 Therapeutics, Inc., founded in 2024, where the title held was Chief Executive Officer & Director from 2024 to 2026.
Mr. Crutcher is also the founder of Helicore Biopharma, Inc.,AstralBio, Inc...
Mr. Crutcher currently serves as Independent Director at Amanat Acquisition Corp.
starting in 2026 and as Director at Jasper Therapeutics, Inc. starting in 2026.
Former positions include President & Chief Executive Officer at AlmataBio, Inc., Chairman & President at Ichorion Therapeutics, Inc. from 2017 to 2018, and Chief Strategy Officer at Avalo Therapeutics, Inc. in 2019.
Education includes graduate studies at the University of California, Los Angeles and undergraduate studies at the University of Illinois.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AVALO THERAPEUTICS INC 1,02 % | 06.08.2025 | 549.467 ( 1,02 % ) | 8 Mio $ | 30.09.2026 |
iBio, Inc.
 iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins 0,87 % | 30.06.2025 | 300.438 ( 0,87 % ) | 354 517 $ | 30.09.2026 |
| 10.08.2026 | 518.331 ( 1,56 % ) | 300 632 $ | 30.09.2026 | |
| 20.07.2026 | 463.452 ( 9,98 % ) | 268 802 $ | 30.09.2026 |
Aktive Positionen von Patrick Crutcher
| Unternehmen | Position | Beginn |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 16.07.2026 |
Ehemalige bekannte Positionen von Patrick Crutcher
| Unternehmen | Position | Ende |
|---|---|---|
ValenzaBio, Inc.
 ValenzaBio, Inc. BiotechnologyHealth Technology Develops treatment options for patients with autoimmune and inflammatory diseases | Gründer | 01.01.2023 |
| AVALO THERAPEUTICS, INC. | Corporate Officer/Principal | 01.11.2019 |
Ichorion Therapeutics, Inc.
 Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceutical products | Vorsitzender | 01.09.2018 |
Ausbildung von Patrick Crutcher
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
27
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Ichorion Therapeutics, Inc.
Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceutical products | Health Technology |
ValenzaBio, Inc.
ValenzaBio, Inc. BiotechnologyHealth Technology Develops treatment options for patients with autoimmune and inflammatory diseases | Health Technology |
Jasper Therapeutics, Inc.
 Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
